New hope for dialysis patients: experimental anemia drug enters final testing phase
NCT ID NCT07494409
First seen Apr 01, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This study tests a new medicine called AND017 for people with anemia caused by end-stage kidney disease who are on dialysis. The goal is to see if AND017 works better than current treatments at keeping red blood cell levels stable. About 300 adults will take part, and the study is currently recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA DUE TO CHRONIC KIDNEY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan Univeristy Zhongshan Hospital
RECRUITINGShanghai, 200032, China
Contact
Conditions
Explore the condition pages connected to this study.